Skip to main content

Certain Pesticides Tied to Increased Prostate Cancer Incidence, Mortality

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 4, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 4, 2024 -- Some pesticides are associated with increased prostate cancer incidence and mortality, according to a study published online Nov. 4 in Cancer.

Simon John Christoph Soerensen, M.D., from the Stanford University School of Medicine in California, and colleagues examined the potential role of agricultural pesticide exposure in prostate cancer incidence and mortality. The annual use of 295 distinct pesticides was measured and the associations with prostate cancer incidence and mortality rates in the contiguous United States were assessed. Data were analyzed for 1997-2001 pesticide use with 2011-2015 outcomes and 2002-2006 pesticide use with 2016-2020 outcomes (discovery and replication cohorts, respectively).

The researchers found that across both cohorts, 22 pesticides showed consistent, direct associations with prostate cancer incidence. Four of these pesticides were also associated with prostate cancer mortality. Each one-standard deviation increase in log-transformed pesticide use corresponded to incidence increases per 100,000 individuals in the replication cohort (6.56, 6.18, 3.20, and 2.82 for trifluralin, cloransulam‐methyl, diflufenzopyr, and thiamethoxam, respectively).

"Public health efforts to reduce the burden of prostate cancer should consider pesticides as environmental exposures that may contribute to the incidence of, and mortality related to, prostate cancer," the authors write

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

Read this next

Pediatric Magnet Ingestion Rates Still High

THURSDAY, May 22, 2025 -- Global pediatric magnet ingestion rates remain high and incidence has increased, despite the implementation of national policies, according to a review...

Stereotactic Body Radiotherapy Feasible After Radical Prostatectomy

TUESDAY, May 20, 2025 -- Post-radical prostatectomy (post-RP) stereotactic body radiotherapy (SBRT) is well tolerated, with patient-reported outcomes (PROs) comparable to those...

MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer

MONDAY, May 19, 2025 -- Use of magnetic resonance imaging (MRI)-guided biopsy (MRGB) could increase the durability of active surveillance (AS) in men with prostate cancer...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.